as the non-specific antigen binding site has been removed from these sequences. proteins, non-specifically, but aptamers increased the levels of these proteins. To understand this we need to highlight the difference between the mechanism of action of siRNA and aptamers. siRNA knocks down the expression of a protein by targeting its mRNA and degrading it. In the process, siRNA may non-specifically degrade mRNA of other Ets family proteins as well. But aptamers do not work through the same mechanism. We suggest that aptamers bind to the Ets1 protein and inhibits the binding of the co-activators and thus hindering the interaction between Ets1 and DNA. As Ets1 is unable to perform its assigned function, the cellular machinery shuts down the production of the Ets1 protein through feedback mechanism. Here comes in the compensatory mechanism which leads to an increase in the levels of Ets2, Elf5 and PDEF. Interestingly, aptamers did not increase the levels of tumour promoters PEA3, Elk and ESE. Further studies are required to explain this interesting behaviour.
Supplementary

Materials and Methods
Cell Lines
H1975, A549, A431, MDA-MB231, MCF-7 were obtained from American Type Cell Culture (ATCC, Manassas). L132, NCI-H460, NCI-H23 and DU-145 cells were from NCCS Pune, India. Cells were grown under standard conditions of 5% CO2 and 37 0 C in controlled humidified incubator. They were cultured in DMEM (A549, A431, MDA-MB231, MCF-7, DU-145 cells), MEM (L132) and RPMI-1640 (H1975, NCI-H460, NCI-H23) media (Sigma Aldrich) supplemented with 10% FBS (Gibco) and 1% penicillin-streptomycin. All the cells were used prior to passage 20. Cells were routinely passaged using 0.25% trypsin/0.1% EDTA.
RNA Library and Primers
The DNA library 5'-C A T C G A T G C T A G T C G T A A C G A T C C-25N C G A G A A C G T T T C T C T C C T C T C C C T A T A G T G A G T C G T A T T A-3' (Sigma) was
amplified by PCR (5 min at 95°C, followed by cycles of 0.5 min at 95°C, 0.5 min at 65°C, and 1 min at 72°C, followed by 2 min at 72°C), with Reverse-Primer 5'-
CATCGATGCTAGTCGTAACGATCC-3' and Forward-Primer 5'-T A A T A C G A C T C
A CTATAGGGAGAGGAGAGAAACGTT CTCG-3'. The resultant dsDNA was converted into RNA library by in-vitro transcription by using epicentre in-vitro transcription kit. The purity of both DNA and RNA was checked on agarose gel.
Selection of Aptamers by Cell SELEX
The RNA library was briefly denatured at 90 °C in 20 ml of selection buffer (EBSS with 1 mM MgCl2), cooled slowly and then warmed up to 37 °C before incubating with counter-selection cell-line L132 cells. After each incubation (60 min each), the unbound RNAs were collected for the next incubation with positive-selection cell H1975 with varied incubation time: 60 min for rounds 1-2, 45 min for rounds 3-5 and 30 min for rounds 6-12. After every incubation the cells were extensively washed before collecting the internalized RNA sequences. The internalized RNA sequences were then extracted using Trizol Reagent (Invitrogen). Selected sequences were treated with DNase (Sigma), before reverse-transcription and PCR amplification. To monitor the enrichment of internalizing aptamer candidates, quantitative PCR method was used to quantify the numbers of PCR cycles carried out to obtain the same amount of PCR products. Subsequently, the PCR products were purified, transcribed into RNA and treated with DNase before starting the next cycle. During the selection, the number of H1975 cells exposed to the RNA library progressively decreased, starting with 1x10 7 and diminishing by 1-2x10 6 cells every other round until reaching 1x10 6 for round 12. After 12 rounds of selection, the resultant samples were given for sequencing.
Quantification of drug conjugated to aptamer
The concentration of nanoparticles bound to aptamer was calculated by HPLC. Aptamer conjugated GNPs were digested overnight in methanol and centrifuged. The supernatant was analyzed for concentration of gefitinib using Shimadzu HPLC system. A C-18 column was used. The mobile phase consisted of 0.02M dipotassium hydrogen ortho phosphate and methanol in the ratio of 10:90 v/v delivered at a flow rate of 1ml/min. 20µl of methanol extract was injected and gefitinib was quantified by UV detection at 246nm.
Partial knockdown of Ets-1 in H1975 cells
Lipofectamine (Invitrogen) was used for transfection assay. Briefly, esiRNA and lipofectamine were individually added to 1.5 ml plain medium without serum and antibiotic each and incubated for 5 minutes at room temperature. Thereafter both esiRNA and lipofectamine solutions were mixed and vortexed. The mixed solution was kept at room temperature for 20 minutes for the formation of esiRNA complex with lipofectamine. After the incubation time, the esiRNA and lipofectamine complex was added to the cells. The medium of the cells was changed after 8 hours so as to avoid any cell death due to the presence of lipofectamine. The cells were then allowed to grow for 48 hours before analyzing them for percentage knockdown and other western blotting studies. Percentage knockdown was calculated by quantitative RT-PCR where cells treated with scrambled esiRNA were considered as control.
qRT-PCR analysis
Total RNA was extracted from H1975 cells, using TRIzol reagent (Invitrogen) and purified using RNeasy kit (Auprep RNeasy mini kit, Life Technologies) according to the manufacturer's instructions. RNA quantity was measured by A260/280 absorbance ratio using 'Nanodrop' and integrity of each sample was assured by agarose gel electrophoresis, respectively. Total RNA prepared from cells was used for cDNA synthesis. 
Transfection of Ets-1 in L132 cells
Briefly, 2 X 10 6 cells were seeded in cell culture dishes and were allowed to achieve 70% confluency before transfection. Transfection reagent lipofectamine was diluted in MEM medium without FBS or antibiotics. The tube was incubated for 5 minutes at room temperature.
5μg of plasmid DNA was diluted in MEM medium without FBS or antibiotics. Thereafter diluted lipofectamine as well as plasmid were combined and allowed to sit at room temperature for 30 minutes. The transfection mixture was then added dropwise to the culture plates in which the cells were grown. Cells were then incubated under standard conditions of 5% CO2 and 37 0 C for 48 hours before testing the effects of over-expression by western blotting.
Protein isolation and Western blotting
H1975 cells were plated for western analysis. Cells were treated with 8µM gefitinib, GNPs and Apt-GNPs for 48 hours. Briefly, treated cells were washed with chilled PBS. The cells were then scraped in lysis buffer and sonicated. The proteins were separated by centrifugation at 10000 rpm for 8 minutes. Protein estimation was performed using Lowry's method. The samples were then prepared for SDS-PAGE and then loaded on polyacrylamide gel. The proteins were transferred on a PVDF membrane which was incubated in presence of anti-p300, anti-MMP-13, anti-tubulin, anti-H3-acetylation, anti-Actin (1:1000 dilution; obtained from Santa Cruz Biotechnology) overnight. The antigen antibody complex was detected using HRPcoupled secondary antibodies (Santa Cruz Biotechnology). Specific bands were detected by chemiluminescence (NOVEX Invitrogen), and visualization was performed by exposure of the membranes to hyperfilm (GE Healthcare).
Statistical Analysis
Tukey's test was performed to determine which groups in the sample differ. It defines a value termed as Honest Significance Difference (HSD) which basically represents the minimum distance between the groups that must be present for a result to be statistically significant.
